Here are relevant reports on : lab-automation-market
-
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application (Infectious, Cancer), Technique, Clinical Application, End User- Global Forecast to 2031
The molecular diagnostics market is estimated at USD 21.68 billion in 2026 and is projected to reach USD 32.56 billion by 2031 at a CAGR of 8.5% during the forecast period. The Key Players Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Illumina, Inc. (US), Abbott (US), bioMérieux (France), Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Revvity, Inc. (US), Myriad Genetics, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (BD) (US), Grifols, S.A. (Spain), QuidelOrtho Corporation (US), DiaSorin S.p.A. (Italy), Exact Sciences Corporation (US), Genetic Signatures (Australia), Agilent Technologies, Inc. (US), MDxHealth (Belgium), Biocartis (Belgium), Bruker (US), TBG Diagnostics Limited (Australia), Amoy Diagnostics Co., Ltd. (China), Vela Diagnostics (Singapore), Molbio Diagnostics Limited (India), geneOmbio Technologies (India), Savyon Diagnostics (Israel), and Uniogen OY (Finland).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Interoperability Solutions Market by Type (Software (EHR, Lab System, Imaging, Health Information Exchange, Enterprises), and Services), Interoperability Level (Foundational, Structural, Semantic), End User, and Region - Global Forecast to 2027
The global Healthcare interoperability solutions market, valued at US$3.0 billion in 2021, stood at US$3.4 billion in 2022 and is projected to advance at a resilient CAGR of 12.9% from 2022 to 2027, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is driven by the government funding to increase adption of healthcare interoperability solutions, and the emergence of new technologies.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drying Equipment Market by Type (Freeze, Spray, Vacuum, Fluidized Bed), Scale of Operation (Industrial-scale, Pilot-scale, Lab-scale), End User (Pharmaceutical Companies, CDMOs, Research Universities) - Global Forecast to 2029
The global pharmaceutical drying equipment market, valued at US$5.45B in 2023, is forecasted to grow at a 7.1% CAGR, reaching US$5.80B by 2024 and US$8.18B by 2029. The expansion of pharmaceutical manufacturing facilities globally, increased demand for biopharmaceuticals such as vaccines, antibodies, and hormones, and the rapid growth of CMOs drive market growth.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Drug Discovery Technologies Market by Product (Instruments, Reagents, Software), Technology (HTS, NGS, PCR, AI-based, Lab-on-chip), Process (Target Identification, Validation, Lead Optimization), Therapeutic Area (Oncology, CVD) - Global Forecast to 2030
The Drug Discovery Technologies market, valued at US$28.61 billion in 2024, stood at US$30.58 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$51.51 billion by the end of the period. The growth of the drug discovery technologies market is driven by the broader use of advanced screening platforms and rising demand for biologics, cell and gene therapies, and RNA-based drugs.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Electronic Lab Notebook Market by Deployment (Cloud (SaaS, PaaS, IaaS)), License (Proprietary, Open source), Component (Software, Services), Organization Size (SME, Large), End User (Pharma & Biotech, NGS, Biobank, Academia) - Global Forecast to 2030
Global electronic lab notebook market valued at $0.68B in 2024, reached $0.72B in 2025, and is projected to grow at a robust 7.3% CAGR, hitting $1.03B by 2030. The adoption of electronic lab notebooks (ELNs) is driven by the growing emphasis on laboratory digitization, the rising need for efficient data management, and integrated compatibility with advanced technologies. Additionally, the increasing use of ELNs within the life sciences sector is expected to fuel their adoption in the life sciences sector.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
The global molecular quality controls market, valued at US$0.2 billion in 2022, stood at US$0.2 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2028, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The growth of this market is primarily driven by the increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, and increasing government funding for genomic projects.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Lab Accessories Market by Type (Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology & Pharmaceutical Companies/Hospital/Private Labs/Research Institute) - Global Forecast to 2020
The laboratory accessories market is valued at $327.0 million in 2014. It is expected to reach $504.7 million by 2020, growing at a CAGR of 7.5% from 2014 to 2020. The laboratory accessories market is dominated by North America, it is followed by Europe, Asia and Rest of the world. The Asian market is the fastest growing in the forecast period (2014-2020). Reagent reservoirs is the fastest-growing segment of this market.
- Published: March 2015
- Price: $ 4950
- TOC Available:
-
Sepsis Diagnostics Market by Technology (Blood Culture, PCR, Immunoassay), Product (Culture, Assay, Instruments), Sample (Serum, blood), Test Type (Lab, POC), Pathogen (Bacterial), End User (Hospital, Pathology & Reference Labs) - Global Forecast to 2031
The global sepsis diagnostic market is projected to reach USD 1.22 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Agriculture Biotechnology Market (Agriculture-Themed Microarrays Lab-on-Chip Devices RNA Interference Assays, Agriculture-Derived Biofuels Chemicals Transgenic Seeds) - 2018 By Application & Geography
- Published: December 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
